Cargando…
Acute hypophysitis secondary to nivolumab immunotherapy in a patient with metastatic melanoma
The treatment for melanoma is challenging because of its nature of being refractory particularly in metastatic stages. Treatment options include surgical resection of the lesion, radiation therapy, chemotherapy, and immunotherapy. Immunotherapy such as anti-cytotoxic T-lymphocyte antigen-4 and anti-...
Autores principales: | Kuru, Sugabramya, Khan, Nazia, Shaaban, Hamid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613411/ https://www.ncbi.nlm.nih.gov/pubmed/28971033 http://dx.doi.org/10.4103/IJCIIS.IJCIIS_15_17 |
Ejemplares similares
-
Nivolumab-induced Hypophysitis, Secondary Adrenal Insufficiency and Destructive Thyroiditis in a Patient with Lung Adenocarcinoma
por: Mishima, Yuka, et al.
Publicado: (2018) -
Late-onset hypophysitis after discontinuation of nivolumab treatment for advanced skin melanoma: a case report
por: Antoniou, Sofia, et al.
Publicado: (2021) -
Spinal Metastasis from Merkel Cell Carcinoma in an Elderly Male
por: Jockisch, Kalah, et al.
Publicado: (2020) -
Secondary Adrenal Insufficiency in a Patient with Metastatic Melanoma Treated with Nivolumab
por: Omata, Wataru, et al.
Publicado: (2022) -
Aplastic anemia secondary to nivolumab and ipilimumab in a patient with metastatic melanoma: a case report
por: Meyers, D. E., et al.
Publicado: (2018)